Studies reveal that the attenuation in the proliferation of prostate cancer cells in vitro and in vivo was mainly through the negative regulation of multidrug resistance-associated protein 1 (MRP1, a glutathione S transferase) by suppressing signal transducer and activator of transcription (STAT3) and NF-κB signaling. This evidence concerns the gene ABCC1 and prostate carcinoma.